Funded Tech Companies
Exicure
Wondering who provided funding to Exicure? Luye Pharma, Eager Info Investments and Knoll Capital Management joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Exicure
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
8045 Lamon Ave. 410
Skokie, IL 60077
USA
Skokie, IL 60077
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
AuraSense Therapeutics is a development-stage biotechnology company founded to pursue the unique commercial potential of Spherical Nucleic Acid (SNA) constructs. These novel constructs possess unparalleled biocompatibility and versatility as therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/7/2017
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Giljohann
Chief Financial Officer
David Snyder
Chief Operating Officer
Matthias Schroff
Company Investors
- Luye Pharma (Li Xin)
- Eager Info Investments
- Knoll Capital Management
- Purple Arch Ventures
- Groupon (Eric Lefkofsky)
- AbbVie Biotech Ventures
- Illumina Ventures (David Walt)
- Katalyst Securities
- Private Investors (Craig Mundie)
- Private Investors (Mark Tompkins)
- Private Investors (Patrick Ryan)
- Private Investors (William Gates)
- Rathmann Family Foundation
- Private Investors (Boon Koh)
- Private Investors (David Walt)
- Cascade Investment (William Gates)
Browse more funded tech companies:
EXFO | Eximia Research Network
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs